Regulatory Advocacy

The AAO-HNS has a long history of working closely with regulatory agencies (e.g., Centers for Medicare & Medicaid Services, U.S. Food and Drug Administration) to maintain our visibility and credibility with national representatives regarding federal regulatory issues.

We believe that advocacy is the key to defining the future of otolaryngology. Federal regulatory advocacy is a top priority of the AAO-HNS.

Academy Summarizes Impact of CMS 2017 Proposed Policies on the Otolaryngology Community
Policies summarized from the CY 2017 Proposed Medicare Physician Fee Schedule (MPFS) that are specific to otolaryngology include: practice expense adjustments; proposed global surgical data collection requirements; Appropriate Use Criteria for Advanced Diagnostic Imaging requirements, modifications to the Qualified Clinical Data Registry (QCDR) qualification requirements, and updates to the Value Based Modifier and Physician Feedback Programs.

Academy Comments to CMS on MIPS and APM Proposed Rule
On June 27, the Academy submitted comments to Centers for Medicare & Medicaid Services (CMS) in response to the Merit-based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Proposed Rule. The Academy commented on the consolidation of existing quality programs into MIPS; the accelerated reporting timeline for physicians; RegentSM and quality measure reporting mechanisms; the complexity of the MIPS scoring system; and the restrictive Advanced APM definition. Access the comments.

Academy Signs onto Letter Regarding the MIPS and APM Proposed Rule
On June 24, the Academy signed onto an American Medical Association (AMA) letter requesting that CMS modify the proposed Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) to simplify the MIPS program, create more opportunities for physicians looking to participate in the Advanced APM pathway, and to provide greater support for physicians in solo, small, or rural practices. Read the letter